Aimei Health Technology (NASDAQ:AFJK) Trading Down 2.2% - Should You Sell?

Key Points

• Shares fell about 2.2% to roughly $45.12 on Wednesday with only ~4,163 shares traded, an 84% drop from the stock's average daily volume, indicating unusually light trading activity.
• Analyst sentiment is negative—MarketBeat shows a consensus "Sell" rating, with recent notes from Wall Street Zen and Weiss Ratings maintaining/downright recommending sell positions.
• Aimei has a market cap of $276.1M and a very high P/E (~214.8), but does not have significant operations and is positioning to pursue a merger or other business combination; institutional investors own about 45.6% of the stock.

Aimei Health Technology Co., Ltd. (NASDAQ:AFJK - Get Free Report) shares dropped 2.2% during trading on Wednesday . The stock traded as low as $45.60 and last traded at $45.1150. Approximately 4,163 shares were traded during mid-day trading, a decline of 84% from the average daily volume of 26,099 shares. The stock had previously closed at $46.12.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the stock. Wall Street Zen raised shares of Aimei Health Technology to a "sell" rating in a research note on Saturday, January 17th. Weiss Ratings reaffirmed a "sell (d+)" rating on shares of Aimei Health Technology in a research note on Friday, March 27th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has a consensus rating of "Sell".

Aimei Health Technology Trading Down 2.2%

The firm has a market capitalization of $276.10 million, a price-to-earnings ratio of 214.84 and a beta of -1.48. The stock's 50 day moving average price is $34.30 and its two-hundred day moving average price is $34.29.

Hedge Funds Weigh In On Aimei Health Technology

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Jane Street Group LLC acquired a new position in Aimei Health Technology during the fourth quarter worth $302,000. Dakota Wealth Management acquired a new position in Aimei Health Technology during the fourth quarter worth $406,000. Geode Capital Management LLC acquired a new position in Aimei Health Technology during the fourth quarter worth $413,000. Quarry LP raised its holdings in Aimei Health Technology by 6.4% during the third quarter. Quarry LP now owns 167,081 shares of the company's stock worth $1,891,000 after purchasing an additional 10,000 shares during the last quarter. Finally, Clear Street Group Inc. raised its holdings in Aimei Health Technology by 36.5% during the fourth quarter. Clear Street Group Inc. now owns 83,337 shares of the company's stock worth $5,334,000 after purchasing an additional 22,294 shares during the last quarter. 45.58% of the stock is owned by institutional investors and hedge funds.

Aimei Health Technology Company Profile

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.